T cells expressing the gamma delta T cell receptor (TcR) often accumulate at sites of inflammation. What role these cells play in disease processes is unclear. However, studies investigating a murine model of coxsackievirus B3 (CVB3)-induced myocarditis imply that these cells modulate CD4+ Th cell responses. Myocarditis generally correlates to the induction of Thl CD4+ cell responses while preferential activation of Th2 cells causes disease resistance. Adoptive transfer of activated gamma delta+ cells into myocarditis-resistant mice results in a shift from Th2 to Thl cell activation and a corresponding induction of myocardial inflammation. These results agree with published reports which state that gamma delta+ cells preferentially downregulate Th2 cell responses. While gamma delta+cells are both potent producers of immunoregulatory cytokines and mediators of Fas-dependent apoptosis, apoptosis may be the primary method of CD4+ cell modulation based on studies using mice expressing either the Ipr or gld mutation. In addition to its effects on CD4+ cell regulation, apoptosis may also be the basis for the induction of dilated cardiomyopathy in myocarditic animals.
The Specific Aims of the present proposal are to: 1) Characterize the gamma delta+ cell populations in the hearts of myocarditic CVB3-infected mice and determine whether all or only selected gamma delta+ cell populations modulate CD4+ Th cell responses; 2) Determine whether gamma delta+ T cells kill Th2 cells through Fas-dependent or non-Fas-dependent pathways; and 3) Evaluate whether co-stimulatory factors on Th2 cell clones promote killing or rescue Thl cells from death.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL058583-02
Application #
2901319
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Wang, Lan-Hsiang
Project Start
1998-04-01
Project End
2002-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Pathology
Type
Schools of Medicine
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Huber, S (2008) Host immune responses to coxsackievirus B3. Curr Top Microbiol Immunol 323:199-221
Huber, Sally A; Feldman, Arthur M; Sartini, Danielle (2006) Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice. Circ Res 99:1109-16
Huber, S A (2006) CD1d expression on hemopoietic cells promotes CD4+ Th1 response in coxsackievirus B3 induced myocarditis. Virology 352:226-36
Huber, Sally; Song, Wen-Chao; Sartini, Danielle (2006) Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis. Viral Immunol 19:156-66
Huber, Sally; Dohrman, Austin; Sartini, Danielle et al. (2006) Reduced myocarditis following Coxsackievirus infection in cellular FLICE inhibitory protein--long form-transgenic mice. Immunology 119:541-50
Huber, S A; Sartini, D (2005) Roles of tumor necrosis factor alpha (TNF-alpha) and the p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis. J Virol 79:2659-65
Huber, Sally (2004) T cells in coxsackievirus-induced myocarditis. Viral Immunol 17:152-64
Huber, Sally; Sartini, Danielle; Exley, Mark (2003) Role of CD1d in coxsackievirus B3-induced myocarditis. J Immunol 170:3147-53
Roessner, Karen; Wolfe, Julie; Shi, Cuixia et al. (2003) High expression of Fas ligand by synovial fluid-derived gamma delta T cells in Lyme arthritis. J Immunol 170:2702-10
Gauntt, Charles; Huber, Sally (2003) Coxsackievirus experimental heart diseases. Front Biosci 8:e23-35

Showing the most recent 10 out of 22 publications